Is There a Best Ivermectin Dosage for Cancers or Different Cancer Types?

Executive Summary

  • We sometimes receive questions about whether there is a different optimal dosage of Ivermectin per cancer type.
  • I cover how we have adjusted our Ivermectin dosage calculator per cancer type.

Introduction

The dosage of Ivermectin changes per cancer type is one of the most common questions we receive at our subscription website.

I will begin by discussing essential considerations when using Ivermectin versus, and then move on to discussing the different dosage calculation for different cancer types in addition to the other inputs that we use to adjust our ivermectin calculation estimate.

Things to Know About Ivermectin for Treating Cancer

These are important considerations to keep in mind when using Ivermectin for different cancer types.

Important Point #1: How Ivermectin Compares Against Other Non-Conventional Cancer Treatments

  • Ivermectin is, in our view, the top non-standard or non-conventional drug for cancer.
  • A close second would be Fenbendazole, which is also an anti-parasitic drug that works against cancer through different mechanisms than Ivermectin, as we cover in the article By How Many Different Mechanisms Does Fenbendazole Fight Cancer?

Important Point #2: Its Use as Both a Treatment and Preventive

  • Ivermectin is very effective against cancer as a treatment but also a cancer-preventative.
  • It can be taken without issue for long periods to both prevent cancer and minimize the recurrence of cancer.
  • We have feedback from many subscribers (see our testimonials article) on the long-term use of Ivermectin, and are long-term users of Ivermectin ourselves at Brightwork Research.

Important Point #3: How Taking Ivermectin is a Much Easier Decision Compared to the Decision on Conventional Cancer Treatments

  • Taking conventional cancer treatments should involve a detailed analysis of the usually complex treatment and its cost-benefit (the subscription site covers all the major traditional cancer treatments in detail).
  • In a high percentage of cases, patients should forego the conventional treatments they are being recommended. However, the vast majority of cancer patients never perform this analysis.
  • The effectiveness level of conventional cancer treatments versus the money spent on developing them, as well as the money spent applying them, has to go down as one of the great failures in the history of medicine.
  • Even if one begins conventional cancer treatments, there is no reason that one cannot also take ivermectin, as it does not negatively affect other cancer treatments. There is no positive impact of chemotherapy. Secondly, as I cover in the article Using Ivermectin as a Backup to Conventional Cancer Treatment, it’s also a good idea to begin ivermectin if one has cancer because one may not be able to complete the conventional cancer treatments that they start.

The Drug Company Strategy of Promoting New On Patent, Less Safe, and Less Effective Drugs Versus Drugs Which are Off Patent

The following quote is from the article Integrative Approaches For Cancer

Pierre Kory considers repurposed drugs to be the achilles heel of the pharmaceutical industry since the entire business depends upon selling incredibly expensive proprietary medicines under the justification it is immensely expensive to prove they are safe and effective—whereas in contrast no money can be made off the repurposed drugs (since their patents expired) which nonetheless must stay legal since they were previously proven to be safe and approved by the FDA.

  • On the other hand, taking Ivermectin requires far less analysis as it provides additional health benefits and is something every cancer patient should be taking.

Important Point #4: How Ivermectin Compares Against Conventional Cancer Treatments for Side Effects

  • As I cover in the articles Answering the Question of Is Ivermectin Safe and Answering the Question of the Side Effects of Ivermectin in Humans, Ivermectin has extremely low side effects compared to any conventional cancer treatment — while traditional cancer treatments are some of the highest side-effect drugs that exist in medicine. In many cases, the only way to get patients to accept conventional cancer treatments is to hide the actual predicted outcomes from the patient.
  • The cost of Ivermectin compared to conventional cancer treatments is very low, while the benefits in most cases will outperform those of conventional cancer treatments.

Getting Into Ivermectin Dosage Calculation

Now that we have established the background of using Ivermectin in cancer treatment, let’s delve into the topic of Ivermectin dosage calculation for different cancer types.

Our Approach to Dosage Estimation Per Cancer Type

Important Item #1: How Studies Are Generally Designed Regarding Dosage

Studies typically do not test different dosage levels during the study, and the benefits associated with each dosage are then compared.

Therefore, the studies do not investigate multiple dosages of Ivermectin for pancreatic, colon, or lung cancer and then publish the results to determine which is best.

Instead, they typically will choose one dosage and then measure if there is an improvement in a cancer outcome. The state of current and previous Ivermectin studies is such that they test whether Ivermectin at a single selected dosage is beneficial.

Important Item #2: How We Use Many More Inputs Than Body Weight to Perform the Dosage Estimate

Virtually all ivermectin dose adjustments only use the individual weight as input to the estimate. This is an extremely oversimplified approach to setting dosage, as multiple factors influence the estimated doses, in addition to weight.

Medicine has a major problem with estimating dosages, which we cover in the article  The Problem With Dosage Calculation in Medicine.

This topic applies to medical dosage estimation in general, and the majority of drugs are not adjusted for body weight. This is referred to as fixed weight dosing. Consequently, people with dramatically different metabolisms and abilities to process drugs through their systems receive the same dosage. Once one analyzes how little thought goes into drug dosage estimation by the pharmaceutical companies, it is amazing to see MDs continue to keep patients on drugs that they are being overdosed on, with the MDs stating that that is the standard dose and should be adhered to.

This case study illustrates a clear case of a patient being overdosed The Problem With Dosage Calculation in Medicine.

How MDs Are Incentivized

This topic raises questions about the ability of most medical doctors to act and think independently. All of the incentives are lined up to get MDs to follow the recommendation precisely, even if they see that a patient is being overdosed and their health is damaged.

An Overfocus on Calculation Errors Versus The Development of Dosage Standards

Generally, the focus of medicine on this topic is addressing medical errors in dosage calculation — that is, deviations from the standard formula. Suppose you type in search terms like “the problems with medical dose estimation” or similar types of questions into search engines. In that case, the topic I am bringing up is not even covered in articles — instead, all of the articles are about miscalculation, not about how the original formulas are developed. 

My point here is different, which is that far too little effort is invested in developing the standard formula during the clinical trial, combined with the standard formulas not being adjusted due to examples from the field, and the dosage not being adjusted according to the patient’s specific capacities and requirements.

Important Item #3: How We Adjust Our Calculator Per the Cancer Type

We have adjusted our cancer dosage estimation based on the time a person has to overcome the cancer or its risk to the patient, taking into account the cancer type. Some cancers provide the patient with less time to beat the cancer because there is a wide range in mortality rates for the different cancer types.

Important Item #4: How We Adjust Our Calculator for Cancer Progression or Stage

We have adjusted our cancer dosage estimation based on both the physical characteristics of the individual and the time a person has to overcome the cancer or its risk to the patient, taking into account both the cancer type and whether the cancer has metastasized.

And, of course, metastasis also means that the time to beat the cancer is shorter than it was before the metastasis occurred.

Important Item #5: How We Adjust Our Calculator for Treatment Versus Maintenance/Prevention

After a person has cancer or if they want to prevent cancer, the calculator adjusts the dosage to be lower than if they are currently treating cancer. Nearly all cancer centers do not provide any recommendation for how to prevent future cancers however that is very important for anybody to do who has gone through having cancer.

Important Item #6: How These Adjustments Occur Within the Calculator

  • We adjust the initial dosage calculation by these factors that increase or decrease the initial dosage calculation.
  • All of this happens within the calculator, so the user sees what our estimate is for their calculated dose.

Seeing a Sample Dosage Calculator

This is how we included a cancer-type adjustment into our Ivermectin cancer dosage calculator. You can see a sample Ivermectin dosage calculator, which includes cancer type, at the Brightwork Research Treatment Database.

The Problem With Generally Available Ivermectin Dosages and Frequencies of Use

When provided by any website from a medical establishment, Ivermectin dosage information will be deliberately set too low and too infrequently. Many other sources will give a dosage for Ivermectin’s use that is not based on cancer studies at all, but rather the standard dose from Merck used when the drug is used to fight parasites.

That is for Ivermectin’s original use. The antiparasite dosage and frequency are not relevant for people looking for a dosage versus cancer.

Our cancer dosage calculators (one for pounds and one for kilograms) are specific to cancers and even adjust per cancer type, sex of the individual, cancer stage etc.

Conclusion

  • We have developed an Ivermectin dosage calculator for cancer that adjusts the doses taken from all Ivermectin cancer studies for multiple factors, including the patient’s sex and cancer type.
  • We have combined multiple factors, including studies on the use of Ivermectin in cancer treatment, anecdotal studies, and the aggressiveness of the cancer type, to develop our dosage calculator.
  • This dosage calculator, along with the rest of the articles on our site, is available exclusively to subscribers. We offer the most extensive collection of articles on both Ivermectin and Ivermectin versus cancer at our subscription site.

About Our Ivermecting Testing Program and Recommended Ivermectin Source of Supply

  • We performed pharmaceutical testing on Ivermectin to find a lower-cost version that also matched Merck's original Ivermectin in bioequivalence.
  • You can read about the details of our Ivermectin testing in this article, Our Ivermectin Bioequivalence Testing.
  • We got Summit Products to carry this version of Ivermectin, which passed our bioequivalence testing.